SBI Securities »

Biodexa Pharmaceuticals shares owned by SBI Securities

Quarter-by-quarter ownership of Biodexa Pharmaceuticals (BDRX) shares owned by SBI Securities from 13F filings

Historical chart of SBI Securities investment in Biodexa Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Biodexa Pharmaceuticals held by SBI Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biodexa Pharmaceuticals by SBI Securities

Quarter filed Position value Share count Share price at filing
2025-09-30 $765 115 6.65

More positions owned by SBI Securities

NVIDIA Corporation (NVDA)
Vanguard S&P 500 ETF Etf (VOO)
Vanguard Total Stock Market ETF Etf (VTI)
Tesla Motors (TSLA)
Apple (AAPL)
Invesco QQQ Trust Series 1 ETF Etf (QQQ)
Palantir Technologies (PLTR)
Microsoft Corporation (MSFT)
Vanguard Total World Stock ETF Etf (VT)
Amazon (AMZN)
Vanguard High Dividend Yield ETF Etf (VYM)
Alphabet Inc Class A cs (GOOGL)
SPDR Portfolio S&P500 HighDividend ETF Etf (SPYD)
Facebook Inc cl a (META)
Direxion Daily Semi Bull 3X Etf (SOXL)

View all positions for SBI Securities

Top funds holding Biodexa Pharmaceuticals

Sabby Management
Hrt Financial
UBS Group
GAMMA Investing
SBI Securities
Rhumbline Advisers

View all funds holding Biodexa Pharmaceuticals